BIOMAT Database Logo BIOMAT Database Logo

Antiviral oligo- and polyribonucleotides containing selected triazolo[2,3-a]purines. 1998

M G Tutonda, and R W Buckheit, and V K Agrawal, and A D Broom
Department of Medicinal Chemistry, 20 South 2030 East, 295 Biomedical Polymers Research Building, University of Utah, Salt Lake City, Utah 84112-9453, USA.

Several amphipathic (hydrophobic base, hydrophilic backbone) polyribonucleotides have recently been shown to have potent antiviral activity against HIV and human cytomegalovirus (HCMV). The working hypothesis developed during these studies was that the ability to form an ordered, non-hydrogen-bonded array in solution was an important criterion for activity. To explore further the role of structure and molecular size on the inhibition of virus replication, one new polynucleotide and two 32-mer oligonucleotides based on the triazolo[2,3-a]purine ring system have now been prepared. High-molecular-weight polynucleotide 4a (PTPR) and sulfur-containing 32-mer 5b (TTPR) were moderately active against HIV but showed greater potency against HDMV than ganciclovir. Both 4a and 5b gave clear evidence of cooperative melting behavior, whereas inactive 32-mer 5a showed no such behavior.

UI MeSH Term Description Entries
D009843 Oligoribonucleotides A group of ribonucleotides (up to 12) in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties.
D010948 Viral Plaque Assay Method for measuring viral infectivity and multiplication in CULTURED CELLS. Clear lysed areas or plaques develop as the VIRAL PARTICLES are released from the infected cells during incubation. With some VIRUSES, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain VIRAL ANTIGENS which can be measured by IMMUNOFLUORESCENCE. Bacteriophage Plaque Assay,Assay, Bacteriophage Plaque,Assay, Viral Plaque,Assays, Bacteriophage Plaque,Assays, Viral Plaque,Bacteriophage Plaque Assays,Plaque Assay, Bacteriophage,Plaque Assay, Viral,Plaque Assays, Bacteriophage,Plaque Assays, Viral,Viral Plaque Assays
D011131 Polyribonucleotides A group of 13 or more ribonucleotides in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties.
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

M G Tutonda, and R W Buckheit, and V K Agrawal, and A D Broom
Antiviral amphipathic oligo- and polyribonucleotides: analogue development and biological studies.
May 2003, Journal of medicinal chemistry,
M G Tutonda, and R W Buckheit, and V K Agrawal, and A D Broom
Purines and triazolo[4,3-e]purines containing pyrazole moiety as potential anticancer and antioxidant agents.
June 2018, Future medicinal chemistry,
M G Tutonda, and R W Buckheit, and V K Agrawal, and A D Broom
Polyribonucleotides containing a phosphorothioate backbone.
April 1970, European journal of biochemistry,
M G Tutonda, and R W Buckheit, and V K Agrawal, and A D Broom
Polyribonucleotides containing a thiophosphate backbone.
February 1969, FEBS letters,
M G Tutonda, and R W Buckheit, and V K Agrawal, and A D Broom
Oligonucleotides and polyribonucleotides: a review of antiviral activity.
January 2005, Antiviral chemistry & chemotherapy,
M G Tutonda, and R W Buckheit, and V K Agrawal, and A D Broom
Helix formation between polyribonucleotides and purines, purine nucleosides and nucleotides. II.
April 1966, Journal of molecular biology,
M G Tutonda, and R W Buckheit, and V K Agrawal, and A D Broom
Polyribonucleotides containing thiopurines: synthesis and properties.
June 1976, Biochemical and biophysical research communications,
M G Tutonda, and R W Buckheit, and V K Agrawal, and A D Broom
"Senseless" antiviral polyribonucleotides: poly (1-propargylinosinic acid).
January 2002, Nucleosides, nucleotides & nucleic acids,
M G Tutonda, and R W Buckheit, and V K Agrawal, and A D Broom
A simple one-pot synthesis of novel [1,2,4]triazolo[3,4-f]purines.
June 2001, The Journal of organic chemistry,
M G Tutonda, and R W Buckheit, and V K Agrawal, and A D Broom
A novel synthesis of 1,2,4-triazolo[1,5-a]isoindolinetrione, 1,2,4-triazolo[1,5-a]pyrimidine and 1,2,4-triazolo[2,3-a]quinazolinedione derivatives and their antibacterial activity.
January 1997, Die Pharmazie,
Copied contents to your clipboard!